The use of technology to assist in care and its effects on quality and costs have been a source of continuing disappointment. Remote monitoring of chronic disease patients has a fairly long history, with uneven results. A new study in the Journal of the American Medical Association suggests that at least one approach to remote monitoring may improve the care of people with hypertension. (JAMA Article) Hypertension is widespread among US adults and while it can be controlled with diet, exercise and inexpensive drugs, physicians have had difficulty keeping patients’ blood pressure in the desired range. Uncontrolled hypertension can lead to adverse events and health care utilization. In a trial conducted at HealthPartners, some patients were remotely monitored and received consulting from trained pharmacists. The pharmacists conducted regular phone visits and emphasized lifestyle changes and medication adherence. At six and 12 months, 57% of the study group had controlled blood pressure versus only 30% in the usual care group. This effect appeared to be maintained for at least 6 months following the end of the study. More drugs were prescribed for the study group and they reported higher adherence to the medication regimen. The cost of the intervention was about $1350 per patient per year. The researchers did not report outcomes related to utilization or cost, but it is highly possible that the intervention group had lower total health spending if their blood pressure was in significantly better control.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace